A NOVEL CELL LINE FOR STUDYING DOPAMINE D2 AND SEROTONIN 5-HT2A HETERODIMERIZATION

被引：0
|
作者：
Gomez Fernandez, S. [1 ]
Lopez-Gimenez, J. F. [2 ]
Varela, M. J. [1 ]
Marcia-Rivas, M. D. [1 ]
Cadavid, M., I [1 ]
Brea, J. [1 ]
Loza, M., I [1 ]
机构：
[1] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, A Coruna, Spain
[2] CSIC, UC, Inst Biomed & Biotechnol Cantabria IBBTEC, Santander, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2015年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
C084
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [1] Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
    Albizu, Laura
    Holloway, Terrell
    Gonzalez-Maeso, Javier
    Sealfon, Stuart C.
    NEUROPHARMACOLOGY, 2011, 61 (04) : 770 - 777
  • [2] Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
    Lukasiewicz, Sylwia
    Polit, Agnieszka
    Kendracka-Krok, Sylwia
    Wedzony, Krzysztof
    Mackowiak, Marzena
    Dziedzicka-Wasylewska, Marta
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (12): : 1347 - 1358
  • [3] Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex
    Szlachta, Marta
    Kusmider, Maciej
    Pabian, Paulina
    Solich, Joanna
    Kolasa, Magdalena
    Zurawek, Dariusz
    Dziedzicka-Wasylewska, Marta
    Faron-Gorecka, Agata
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [4] New hexahydrocarbazoles and spiro indoles, and their affinity for D2 dopamine and 5-HT2A serotonin receptors
    Fernández, F
    García-Mera, X
    Rodríguez, G
    Urrutia, A
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (07) : 1006 - 1009
  • [5] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects
    Karlsson, P
    Dencker, E
    Nyberg, S
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S386 - S386
  • [6] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects
    Karlsson, P
    Dencker, E
    Nyberg, S
    Cselenyi, Z
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 85 - 86
  • [7] HALLUCINOGENIC LIGAND (±)DOI MODULATE DOPAMINE D2 SIGNALING BY ACTIVATING 5-HT2A PROTOMERS OF A 5-HT2A/D2 HETEROOLIGOMER
    Gomez-Garcia, L.
    Gomez, S.
    Cadavid, M. I.
    Brea, J.
    Loza, M. I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 70 - 71
  • [8] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
  • [9] Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia
    Akash Rathore
    Vivek Asati
    Mitali Mishra
    Ratnesh Das
    Varsha Kashaw
    Sushil Kumar Kashaw
    In Silico Pharmacology, 10 (1)
  • [10] Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist
    Ohno, Yukihiro
    Okano, Motoki
    Imaki, Junta
    Tatara, Ayaka
    Okumura, Takahiro
    Shimizu, Saki
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 96 (02) : 175 - 180
12345